To address the current national emergency, U.S. entities may be eligible to license select Sandia intellectual property at no cost for a limited time. Learn more.

Search/Browse Tech

Preconcentration and separation of analytes in microchannels

United States Patent

To discuss licensing opportunities, fill out our Contact Form 
November 9, 2010
View the Complete Patent at the US Patent & Trademark Office
Microscale Immune and Cell Analysis (MICA)
Rapid Automated Point-of-Care System (RapiDx)
Disclosed herein are methods and devices for preconcentrating and separating analytes such as proteins and polynucleotides in microchannels. As disclosed, at least one size-exclusion polymeric element is adjacent to processing area or an assay area in a microchannel which may be porous polymeric element. The size-exclusion polymeric element may be used to manipulate, e.g. concentrate, analytes in a sample prior to assaying in the assay area.
Hatch; Anson (Tracy, CA), Singh; Anup K. (Danville, CA), Herr; Amy E. (Fremont, CA), Throckmorton; Daniel J. (Tracy, CA)
Sandia Corporation (Livermore, CA)
September 29, 2006
204/455 ; 204/605;
B01D 57/02 (20060101); B01D 61/58 (20060101); B01D 63/00 (20060101);
ACKNOWLEDGEMENT OF GOVERNMENT SUPPORT This invention was made with Government support under government contract DE-AC04-94AL85000 awarded by the U.S. Department of Energy to Sandia Corporation. The Government has certain rights in the invention.